Xarelto - Side Effects & Injuries

Xarelto News

Xarelto Injuries & Deaths Up By Over 40% in 2016

As the third lawsuit against Janssen Pharmaceuticals and Bayer AG gets underway, the Institute for Safe Medication Practices (ISMP) has released a disturbing report: the number of injuries and fatalities attributed to the anticoagulant medication Xarelto in 2016 was up by more than 40 percent over the previous year....

In The Face of Growing Litigation, Xarelto Makers Seek New Customers

Bayer Healthcare and Janssen Pharmaceuticals, manufacturers of the anti-coagulant Xarelto (rivaroxaban), currently face more than 15,000 lawsuits, alleging that they were aware of the risk of dangerous and even fatal bleed-outs and failed to inform the public as well as the medical community.Although there is at present no...
Xarelto Heart Study

Bayer and Janssen Call Off Clinical Trial for Xarelto – Apparently, They Don’t Think it’s Needed Anymore

The most recent clinical study of Xarelto (rivaroxaban) has been halted more than a year early, because Bayer AG, the drug's original developer and sponsor of the trial, is satisfied with the results. That study, known as “Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral...

Xarelto Lawsuits Pass the 15,000 Mark – Meanwhile, an Antidote is Still On Hold

As of mid-December 2016, Janssen Pharmaceuticals is facing more than 15,000 lawsuits (most of which have been consolidated into multidistrict litigation in Louisiana with approximately 1,000 scheduled in Pennsylvania) over its “new generation” anti-coagulant medication, Xarelto (riraroxaban).Federal trials will get underway in March of 2017, while state-level cases won't...
Xarelto Alere Clinical Trial

Did A Faulty Blood Monitor Affect The Outcome of the Xarelto Clinical Trial?

Recently, the British Medical Journal (BMJ) published a report regarding a clinical trial that resulted in FDA approval of the anticoagulant medication Xarelto (rivaroxaban). It involved the use of a device known as the INRatio, a meter designed to monitor the levels of such medications in a patient's blood....
Xarelto Bleeding Cure

FDA Delays Approval of Xarelto Antidote

As the number of lawsuits against Xarelto manufacturer Bayer approaches 7,000, the company has received more bad news: FDA approval for the much-anticipated antidote, under development by a small California-based biotech firm, has been delayed.Xarelto (rivaroxaban) is one of the “new generation” of anticoagulant medications that have been developed...

FDA Ignores Faulty Data in Approving Xarelto

For some time, there have been serious questions about the ROCKET-AF trial, the clinical study of the anti-coagulant medication Xarelto (rivaroxaban), prescribed for patients at risk for stroke. The study compared the performance of  Xarelto to that of warfarin, the standard treatment for nearly seven decades. Specifically, the medical...

Celebrities Have No Problem Endorsing Dangerous Drugs Such as Xarelto

As the number of Xarelto lawsuits approaches 2,000 and the drug’s connection to fatal bleeding becomes more widely known, manufacturer Janssen Pharmaceutica is pulling out all the stops on its marketing campaign – including a recent television ad featuring a quartet of prominent celebrities.The four celebrities –  NBA player...

Bayer Funds Study Claiming Xarelto Not Causing Uncontrollable Bleeding

Rivaroxaban, better known as Xarelto®, has been associated with hundreds of adverse events involving fatal and near-fatal hemorrhaging since it received FDA approval in 2011. Within three years of its arrival on pharmacy shelves, the number of injuries due to Xarelto’s side effects has surpassed those caused by rival...
Xarelto Videos
Additional Information

To review more information regarding Xarelto (including scientific studies, government warnings, recalls and litigation), visit Xarelto Info, a comprehensive webpage maintained by the law firm of Levin Papantonio.